CGTBiologicstaleKite, A Gilead CompanyPhase 2
Murine autologous anti-CD19 chimeric antigen receptor T cells (Murine autologous anti-CD19 chimeric antigen receptor T cells)
Acute Lymphoblastic Leukemia, Pediatric; Acute Lymphoblastic Leukemia, in Relapse · CD19
#CD19#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 88%임상시험 1상태 ACTIVE